Provided by Tiger Trade Technology Pte. Ltd.

Beta Bionics, Inc.

19.05
+0.07000.37%
Volume:636.60K
Turnover:12.04M
Market Cap:848.90M
PE:-11.55
High:19.44
Open:18.96
Low:18.39
Close:18.98
52wk High:32.71
52wk Low:8.80
Shares:44.56M
Float Shares:26.52M
Volume Ratio:0.63
T/O Rate:2.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6486
EPS(LYR):-1.8100
ROE:-26.16%
ROA:-16.67%
PB:3.31
PE(LYR):-10.52

Loading ...

Beta Bionics Secures FDA Clearance for Mint Patch Pump

TIPRANKS
·
Sep 16

Beta Bionics $125M Spot Secondary; price range $17.00-$17.50

TIPRANKS
·
Sep 16

Diabetes Device Firm Beta Bionics Slides on $125 Mln Stock Offering Plans

Reuters
·
Sep 16

Beta Bionics announces $125M common stock offering

TIPRANKS
·
Sep 16

Beta Bionics Plans USD 125 Million Common Stock Offering

Reuters
·
Sep 16

Beta Bionics, - Grants Underwriters 30-Day Option for $18.75 Mln Additional Shares

THOMSON REUTERS
·
Sep 16

Beta Bionics, - to Use Proceeds for Mint Commercialization, Manufacturing, R&D, and Working Capital

THOMSON REUTERS
·
Sep 16

Beta Bionics Announces Proposed Public Offering of $125.0 Million of Common Stock

THOMSON REUTERS
·
Sep 16

Beta Bionics Price Target Raised to $20.00/Share from $18.00 by B of a Securities

Dow Jones
·
Sep 16

Beta Bionics, Inc. : Truist Securities Raises Target Price to $23 from $22

THOMSON REUTERS
·
Sep 15

Analysts Offer Insights on NA Companies: Beta Bionics, Inc. (BBNX), Meta Platforms (META) and Turn Therapeutics Inc (TTRX)

TIPRANKS
·
Sep 15

Analysts Offer Insights on NA Companies: General Dynamics (GD), Alphabet Class A (GOOGL) and Beta Bionics, Inc. (BBNX)

TIPRANKS
·
Sep 14

Beta Bionics Lowers 2026 Revenue Guidance, Receives FDA Clearance for Mint Patch Pump

MT Newswires Live
·
Sep 14

Beta Bionics price target raised to $27 from $24 at Leerink

TIPRANKS
·
Sep 14

Truist Lifts Price Target on Beta Bionics to $23 From $22, Keeps Buy Rating

MT Newswires Live
·
Sep 14

Analysts’ Opinions Are Mixed on These NA Stocks: Lineage, Inc. (LINE), Beta Bionics, Inc. (BBNX) and Huron Consulting (HURN)

TIPRANKS
·
Sep 14

Beta Bionics Announces FDA Clearance of Mint™, the Company’s Transformative Patch Pump, and Unveils 3D Intelligence™ as Its Next-Generation Insulin Dosing Algorithm

THOMSON REUTERS
·
Sep 14

Beta Bionics, - Estimates Fy2026 Total Revenue of $121 Mln-$126 Mln

THOMSON REUTERS
·
Sep 14

Beta Bionics, - Mint Full U.S. Commercialization Expected to Begin in Q1 2027

THOMSON REUTERS
·
Sep 14

Beta Bionics, Inc.: During FY 2027, Expects Mint to Recapture Any Revenue Lost in Q4 2026

THOMSON REUTERS
·
Sep 14